BURNABY, British Columbia (AP) 鈥� BURNABY, British Columbia (AP) 鈥� Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $110.7 million in its second quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of $1.11.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.16 per share.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/XENE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
